In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 01, 2015
Source ID
10.1007/s10549-015-3282-x

Entities

People

  • Amrita J. Desai
  • David Chen
  • Dennis J. Slamon
  • Dylan Conklin
  • Judy Dering
  • Lee Anderson
  • Neil A O'Brien
  • Ondrej Kalous
  • Richard S. Finn
  • Ronald Linnartz
  • Sara A. Hurvitz
  • Teodora Kolarova

Organizations

  • National Cancer Institute
  • United States Department of Defense